9-113267373-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_139286.4(CDC26):c.148C>T(p.Leu50Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000967 in 1,602,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139286.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDC26 | NM_139286.4 | c.148C>T | p.Leu50Phe | missense_variant | 4/4 | ENST00000374206.4 | NP_644815.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDC26 | ENST00000374206.4 | c.148C>T | p.Leu50Phe | missense_variant | 4/4 | 1 | NM_139286.4 | ENSP00000363322 | P1 | |
CDC26 | ENST00000490408.5 | n.400+5054C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000659 AC: 10AN: 151670Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000156 AC: 38AN: 242988Hom.: 0 AF XY: 0.000190 AC XY: 25AN XY: 131270
GnomAD4 exome AF: 0.0000999 AC: 145AN: 1450966Hom.: 0 Cov.: 30 AF XY: 0.000154 AC XY: 111AN XY: 721464
GnomAD4 genome AF: 0.0000659 AC: 10AN: 151790Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74174
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2023 | The c.148C>T (p.L50F) alteration is located in exon 4 (coding exon 2) of the CDC26 gene. This alteration results from a C to T substitution at nucleotide position 148, causing the leucine (L) at amino acid position 50 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at